| NCT ID | NCT05838950 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Syracuse University |
| Condition | Obesity |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2023-09-29 |
| Primary Completion | 2025-08-23 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2023-09-29 with a primary completion date of 2025-08-23.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary aim of this randomized clinical trial is to compare the effects of three different HIIT protocols and a control group on cardiometabolic health in young adults with obesity. Participants will be randomly assigned to one of the following three groups, with each having varying work-to-rest ratios: 1) HIIT-A, 2) HIIT-B, 3) HIIT-C, and 4) control group. HIIT-A, HIIT-B, and HIIT-C groups will participate in six sessions of a running based HIIT program over a 2-week training period. Pre-clinical markers of cardiovascular disease, blood lipids and fasting glucose will be measured at the following three time points: baseline, post-intervention, and 2 weeks after the training cessation (i.e., measure for detraining effect). All measurements will be performed three days before the training program and three days after the intervention to avoid the effect of the last training session. Afterwards, the detraining test will be measured 2 weeks post intervention.
Eligibility Criteria
Inclusion Criteria: * Young adults with obesity (Age 18 to 25 years old, BMI ≥ 30 kg/m2). Exclusion Criteria: * Syndromic obesity; 1) Any clinical symptoms including cognitive delay, 2) abnormalities in body structure(s), 3) organ-specific abnormalities (kidney, liver failure, excessive eating, and/or other signs of hypothalamic dysfunction such as fatigue, weakness and/or lack of interest in activities. * Taking weight loss medication(s) * Currently enrolled (or within previous 6 months) in a weight loss program; * An underlying disease/medications (steroids, second generation psychotropic agents, hormonal contraception, statins, antihypertensive and antidiabetic medications) that could influence carbohydrate or lipid metabolism. * Presence of cardiac pacemaker. * Current or anticipated participation in another research that would interfere with any of the outcomes. * Current or anticipated pregnancy.
Contact & Investigator
Joon Young Kim, Ph.D
PRINCIPAL INVESTIGATOR
Syracuse University, Departments of Exercise Science
Frequently Asked Questions
Who can join the NCT05838950 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 25 Years, studying Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05838950 currently recruiting?
Yes, NCT05838950 is actively recruiting participants. Contact the research team at mseo04@syr.edu for enrollment information.
Where is the NCT05838950 trial being conducted?
This trial is being conducted at Syracuse, United States.
Who is sponsoring the NCT05838950 clinical trial?
NCT05838950 is sponsored by Syracuse University. The principal investigator is Joon Young Kim, Ph.D at Syracuse University, Departments of Exercise Science. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.